← peptides typeshit

Motley Fool picks Foundayo, Onswik and retatrutide as Eli Lilly's next growth drugs

An investor take on Lilly's pipeline. One stat stands out: Lilly said 80% of Foundayo prescriptions went to people new to GLP-1 drugs.

Read at Yahoo Finance

Recap by typeshit. Full story at Yahoo Finance.